Dosimetric and radiobiologic comparison of 103Pd COMS plaque brachytherapy and Gamma Knife radiosurgery for choroidal melanoma
- PMID: 28161431
- DOI: 10.1016/j.brachy.2016.12.003
Dosimetric and radiobiologic comparison of 103Pd COMS plaque brachytherapy and Gamma Knife radiosurgery for choroidal melanoma
Abstract
Purpose: Plaque brachytherapy (BT) and Gamma Knife radiosurgery (GKRS) are highly conformal treatment options for choroidal melanoma. This study objectively compares physical dose and biologically effective dose (BED) distributions for these two modalities.
Methods and materials: Tumor and organ-at-risk (OAR) dose distributions from a CT-defined reference right eye were compared between 103Pd COMS (Collaborative Ocular Melanoma Study Group) plaques delivering 70 Gy (plaque heterogeneity corrected) over 120 h to the tumor apex and GKRS plans delivering 22 Gy to the 40% isodose line for a representative sample of clinically relevant choroidal melanoma locations and sizes. Tumor and OAR biologically effective dose-volume histograms were generated using consensus radiobiologic parameters and modality-specific BED equations.
Results: Published institutional prescriptive practices generally lead to larger tumor and OAR physical doses from COMS BT vs. GKRS. Radiobiologic dose conversions, however, revealed variable BEDs. Medium and large tumors receive >1.3 times higher BEDs with COMS BT vs. GKRS. OAR BEDs have even greater dependence on tumor size, location, and treatment modality. For example, COMS BT maximum BEDs to the optic nerve are lower than from GKRS for large anterior and all posterior tumors but are higher for anterior small and medium tumors.
Conclusions: BT and GKRS for choroidal melanoma have different physical dose and BED distributions with potentially unique clinical consequences. Using published institutional prescriptive practices, neither modality is uniformly favored, although COMS BT delivers higher physical doses and BEDs to tumors. These results suggest that lowering the physical prescription dose for COMS BT to more closely match the BED of GKRS might maintain equivalent tumor control with less potential morbidity.
Keywords: Choroidal melanoma; Dosimetry; Eye plaque; Gamma Knife; Radiobiology; Radiosurgery.
Copyright © 2017 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.Med Phys. 2012 Oct;39(10):6161-84. doi: 10.1118/1.4749933. Med Phys. 2012. PMID: 23039655
-
Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.Med Phys. 2012 Jun;39(6):3332-42. doi: 10.1118/1.4718683. Med Phys. 2012. PMID: 22755715
-
Review of the poster "Dosimetric comparison of gamma knife radiosurgery vs. 125I plaque brachytherapy in a cohort of choroidal melanomas".Med Dosim. 2009 Summer;34(2):107-9. doi: 10.1016/j.meddos.2008.05.002. Epub 2008 Jun 10. Med Dosim. 2009. PMID: 19410138 Review.
-
Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):844-8. doi: 10.1016/j.ijrobp.2009.08.059. Epub 2010 Feb 19. Int J Radiat Oncol Biol Phys. 2010. PMID: 20171804
-
Ocular complications following I-125 brachytherapy for choroidal melanoma.Eye (Lond). 2009 Jun;23(6):1254-68. doi: 10.1038/eye.2009.43. Epub 2009 Mar 6. Eye (Lond). 2009. PMID: 19265865 Review.
Cited by
-
Current and Emerging Radiotherapy Options for Uveal Melanoma.Cancers (Basel). 2024 Mar 6;16(5):1074. doi: 10.3390/cancers16051074. Cancers (Basel). 2024. PMID: 38473430 Free PMC article. Review.
-
Visual outcome after posterior uveal melanoma episcleral brachytherapy including radiobiological doses.J Contemp Brachytherapy. 2018 Apr;10(2):123-131. doi: 10.5114/jcb.2018.75597. Epub 2018 Apr 30. J Contemp Brachytherapy. 2018. PMID: 29789761 Free PMC article.
-
Radiobiological doses, tumor, and treatment features influence on local control, enucleation rates, and survival after epiescleral brachytherapy. A 20-year retrospective analysis from a single-institution: part I.J Contemp Brachytherapy. 2018 Aug;10(4):337-346. doi: 10.5114/jcb.2018.77849. Epub 2018 Aug 31. J Contemp Brachytherapy. 2018. PMID: 30237817 Free PMC article.
-
Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study.J Contemp Brachytherapy. 2021 Oct;13(5):563-574. doi: 10.5114/jcb.2021.110349. Epub 2021 Oct 29. J Contemp Brachytherapy. 2021. PMID: 34759981 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous